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Abstract
Neuroproteomics is a powerful platform for targeted and hypothesis driven research, providing comprehensive insights into
cellular and sub-cellular disease states, Gene6Environmental effects, and cellular response to medication effects in human,
animal, and cell culture models. Analysis of sub-proteomes is becoming increasingly important in clinical proteomics,
enriching for otherwise undetectable proteins that are possible markers for disease. Membrane proteins are one such sub-
proteome class that merit in-depth targeted analysis, particularly in psychiatric disorders. As membrane proteins are
notoriously difficult to analyse using traditional proteomics methods, we evaluate a paradigm to enrich for and study
membrane proteins from human post-mortem brain tissue. This is the first study to extensively characterise the integral
trans-membrane spanning proteins present in human brain. Using Triton X-114 phase separation and LC-MS/MS analysis,
we enriched for and identified 494 membrane proteins, with 194 trans-membrane helices present, ranging from 1 to 21
helices per protein. Isolated proteins included glutamate receptors, G proteins, voltage gated and calcium channels,
synaptic proteins, and myelin proteins, all of which warrant quantitative proteomic investigation in psychiatric and
neurological disorders. Overall, our sub-proteome analysis reduced sample complexity and enriched for integral membrane
proteins by 2.3 fold, thus allowing for more manageable, reproducible, and targeted proteomics in case vs. control
biomarker studies. This study provides a valuable reference for future neuroproteomic investigations of membrane proteins,
and validates the use Triton X-114 detergent phase extraction on human post mortem brain.
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Introduction
Membrane proteins are at the interface between the cell and its
external environment making them instrumental in synaptic and
neuronal transmission via cell adhesion, cellular trafficking, and
ion transport. These processes are known to be disrupted in
neuropathological disorders such as Alzheimer’s disease, Parkin-
son’s disease, and schizophrenia. Furthermore, membrane pro-
teins constitute one-third of the total proteins encoded by the
human genome [1] making them important pharmacological and
biomarker targets for drug development. Intriguingly, greater than
60% of the major pharmaceutical drug targets are known
membrane proteins [2], emphasizing their crucial role in cellular
dynamics and disease processes.
Despite years of extensive research, comprehensive analysis of
membrane proteins is challenging to say the least [1,3,4]. Integral
membrane proteins are defined as transmembrane proteins, with a
hydrophobic domain that interacts directly with the hydrophobic
core of the lipid bilayer. Thus making analysis by conventional 2-
D gel-based techniques difficult due to their poor solubility, basic
pH, low molecular weight, and tendency to aggregate out of
solution [5]. As a consequence, membrane protein analysis is often
approached by an enrichment process followed by tryptic
digestion and analysis at the peptide level by LC-MS/MS [6].
Strategies traditionally used for enriching for membrane
proteins (for review see [3]), include 1) sub-cellular fractionation
with a series of centrifugations, or with a sucrose density gradient
centrifugation, 2) delipidation to remove the lipid bilayer
surrounding the transmembrane helices, 3) affinity purification,
and 4) removal of non-membrane proteins using high salt and high
pH (3). These multistep protocols are often used in combination
with each other to achieve sufficient power, and require large
amounts of starting material. In addition, they can incur large
protein losses and artifactual contamination. A fifth less docu-
mented enrichment method, phase separation, is not widely
known in proteomics [7], yet it offers huge potential for routine
enrichment and purification of membrane proteins prior to LC-
MS/MS. Triton X-114 separation was first introduced by Bordier
in the early 1980’s [8] and has traditionally been used to enrich for
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and study membrane proteins in bacteria [9–11], although more
recently it has been applied to yeast [12], mouse liver [13], human
cardiac tissue [6], and porcine brain [14]. To our knowledge, this
is the first time phase separation using the Triton X-114 detergent
has been applied to human post-mortem brain. Partitioning of the
membrane and aqueous proteins is achieved by heating the Triton
X-114 to temperatures above 20uC, until it reaches its cloud point.
The detergent enters and partitions the lipid bilayer releasing the
otherwise insoluble transmembrane proteins [6]. A simple low-
speed centrifugation step recovers the membrane proteins in the
detergent phase as an oily pellet, while aqueous proteins are
resolved in the supernatant. As protocols with detergent/
membrane combinations have not been well documented or
qualified for human brain tissue, the aim of this study was to 1)
perform phase separation of detergent and aqueous phase proteins
in human post-mortem brain using Triton X-114, and 2) confirm
enrichment for membrane proteins in the detergent phase using
proteomics. The various proteomic strategies applied in this
manuscript are outlined in the study design in Figure 1.
Results
Triton X-114 Phase Separation
Following phase separation, protein yield as determined by the
Bradford dye binding assay (BioRad), was estimated at 0.45 mg/ml
for the Detergent (DT) phase extract, 1.36 mg/ml for the Aqueous
(AQ) phase extract, and the recovered Pellet (Pt) had 3.38 mg/ml of
protein. Results are based on the average of three samples (Table
S1). Each fraction was resolved in 1 ml of the appropriate buffer,
giving a total of 0.45 mgs for the DT phase, 1.36 mgs for the AQ
phase, and 3.38 mgs for the recovered Pt.
1D-SDS and Western Blotting
Comparisons of the protein banding patterns across samples
(10 mg protein/sample) revealed unique DT and AQ phase
protein fractions, following phase separation (Figure 2). The DT
phase was particularly enriched in protein in the low Mw region
(2–15 kD) in comparison to C and AQ samples, while the medium
to high Mw region (15–250 kD) was depleted with very light
banding in comparison to other samples. In contrast, the AQ
phase banding pattern was much more complex with proteins
abundantly distributed across Mw regions. Finally, the recovered
Pt exhibited patterns similar to that of C tissue with strong bands
present at 50 kD and 15 kD. In support, western blotting (Figure 3)
was used to show an increase in the abundant membrane
associated brain protein MBP [15,16] (18–20 kD), in the DT
fraction in comparison to the AQ phase (Figure 3a). MBP was also
strongly represented in the C and in the recovered Pt at 24 kD,
however the banding pattern differed to that of the DT phase,
where it was enriched in the 18–20 kD region (as specified in the
Chemicon MAB386 data sheet), in comparison to the AQ phase.
GAPDH is a well documented marker of the cytosol [17,18], and
we found this protein enriched in the AQ phase at 40 kD, as
expected, and completely depleted in the DT phase and Pt
fractions (Figure 3b). Together, these results suggest that phase
separation of proteins into DT and AQ fractions was achieved,
using the Triton X-114 technique.
Figure 1. Study design for Triton X-114 phase separation on
human post-mortem brain tissue. a) Following phase partitioning
for two out of the three samples fractionated, Aqueous (AQ) and
Detergent (DT) phase proteins, as well as proteins lost to the pellet (Pt),
were identified by LC-MS/MS analysis. Identified proteins were classified
according to sub-cellular location using GoMiner, and TMHMM was
used to predict the number of transmembrane helices present in each
protein. In b) DT and AQ phase proteins from one of the samples were
isolated by acetone precipitation, resuspended in 2D-PAGE buffer, and
separated by isoelectric focusing in the first dimension, and SDS- PAGE
in the second dimension. The large format 2D gels underwent silver
staining, and 96 of the DT phase proteins were randomly excised for
identification by LC-MS/MS. Identified proteins were classified accord-
ing to sub-cellular location using GoMiner, and TMHMM was used to
predict the number of transmembrane helices present.
doi:10.1371/journal.pone.0039509.g001
Figure 2. Coomassie blue staining confirming phase separation
of DT and AQ phase fractions in comparison to control (C) non-
enriched tissue. Proteins in the DT phase appear enriched at the low
Mw region (2 kD to 15 kD) in comparison to other fractions, while
protein in the 15 kD –250 kD Mw range appears depleted. The AQ
fraction is much more complex with proteins distributed abundantly
from high to low Mw, particularly enriched in the 15 kD to 75 kD region
in comparison to the DT phase. The banding pattern for proteins
recovered from the Pt is similar to that of control tissue, as expected,
with strong bands at 50 kD and 15 kD.
doi:10.1371/journal.pone.0039509.g002
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LC-MS/MS of Triton X-114 Phase Extractions
In order to fully characterise the protein profile of DT and AQ
phase extractions, and assess the protein lost to the Pt, samples
were digested to peptides and injected online to a Thermo LTQ-
Orbitrap. Two independent samples from each fraction were
injected on the MS. For comparative reasons, non-enriched
control tissue from the same cortical brain region also underwent
LC-MS/MS analysis for protein identification. Proteins were
identified according to the criteria presented in the materials and
methods section. On average, 726 proteins were identified in the
DT phase extracts (Tables S2, S3, and S4), 257 proteins in the AQ
phase (Tables S5, S6, and S7), and 382 proteins were recovered in
the Pt (Tables S8 and S9). The number of identified proteins in
each phase are summarised in Figure 4(a). A total of 602 proteins
were identified in the control non-enriched sample from the
insular cortex (Table S10). The number of identified proteins that
overlapped between DT, AQ and Pt fractions for both samples are
presented in Figure S1. By combining the two independent DT
phase samples a total of 1154 unique proteins were identified
(Table S2), including 494 (54%) membrane proteins, following the
removal of 279 duplicate entries. Likewise, combined AQ phase
samples revealed a total of 384 unique protein identifications, after
the removal of 129 duplicate entries (Table S5).
Gene Ontology and Transmembrane Helices Calculations
GoMiner was used to assign a membrane, cytosolic, or
cytoskeletal sub-cellular ontology to identified proteins
(Figure 4b). Gene ontology classification revealed an increase in
membrane proteins present in the DT phase in comparison to the
AQ phase, and the Pt. These results are based on average of two
independent samples per fraction. It is also noteworthy that a large
number of cytoskeletal proteins were present in the DT phase,
suggesting these groups of proteins strongly associate with each
other. To further characterise the properties of the DT, AQ, Pt
and C samples, we used the TMHMM Server to identify the
number of transmembrane spanning helices per protein, in each
fraction. The number of helices present ranged from 1 to 21 for
each protein. The results are summarised in Table 1, and are
illustrated as a bar chart in Figure 5, which clearly shows an
increased number of transmembrane domains present in the DT
phase proteins in comparison to the AQ phase, protein Pt, and C
sample. Most notable are the 99 proteins with at least 1
transmembrane domain, and 23 proteins with 2 transmembrane
helices. Numbers of helices identified for each of the Triton-X114
phases are based on the average of two samples. DT phase
proteins had an average of 194 transmembrane helices, repre-
senting a 5.5 fold increase in comparison to the average number of
helices present in AQ phase proteins, and a 2.3 fold increase in
comparison to control non-enriched tissue from the same brain
region. Also notable is the similar number of helices present in the
control sample and in protein lost to the Pt, in keeping with the
similar banding patterns observed for both samples in Figure 2.
This data further confirms the uniqueness of the DT phase
fraction, that is abundant with large membrane spanning proteins.
2D-PAGE of Triton X-114 Phase Fractions
2D-PAGE and subsequent silver staining of the DT and AQ
phase large format gels produced good quality protein spot
patterns (Figure S2), with the AQ phase being more complex and
having an increased number of protein spots in comparison to the
DT phase. The DT fraction had a well resolved protein spot
pattern, which was surprising given the hydrophobic nature of the
proteins (Figure 6). We randomly excised 96 of these membrane
protein spots and successfully identified 92 by LC-MS/MS (Table
S11). Of the 92 identified proteins, 77 were unique observations
and could be assigned gene symbols for GO ontology classification
according to sub-cellular location. Results confirmed enrichment
of membrane proteins with 62% (48) of the 77 observations being
of membrane protein ontology, while 14% (11) were assigned to
the cytoskeleton protein class, and 6.5% (5) were assigned as
having a cytosolic protein ontology. Figure 6 summarises the sub-
cellular location of the membrane proteins resolved by 2D-PAGE
and identified by LC-MS/MS.
Discussion
Analysis of sub-proteomes and otherwise undetectable protein
classes is becoming increasingly important in the field of
neuroproteomics, where recent investigations have enriched for
and studied the post-synaptic density [19], lipid rafts [20], the
myelin proteome [21,22], neuromelanin granules [23], and the
calmodulin-binding proteome [24], in human post mortem brain.
In this study, we propose a paradigm to enrich for and study
membrane proteins in human post-mortem brain. As integral
membrane proteins are at the interface between the cell and
external environment, and sub-cellular structures, they are
important mediators of cell-to –cell signalling, synaptic transmis-
sion, cellular transport [4], and neuroleptic activity. Analysis of this
sub-proteome in patients and disease models will greatly aid
pathophysiological investigations, yet such studies have not been
broadly applied due to the difficulty in recovering and resolving
transmembrane proteins.
We applied Triton X-114 phase separation to human cortical
tissue and confirmed phase separation into DT and AQ phases by
comparing the protein banding pattern between control non-
enriched tissue and DT and AQ phases (Figure 2). In support,
western blotting showed increased expression of transmembrane
spanning protein MBP in the DT phase in comparison to the AQ
phase (Figure 3), while cytosolic protein GAPDH was depleted in
the DT phase and enriched in the AQ phase, as expected. Our
LC-MS/MS experiment identified a total of 1154 unique DT
phase proteins (Table S2), and confirmed enrichment where 54%
(494) were of membrane protein ontology. DT phase proteins had
an average of 194 transmembrane domains present (Figure 5),
representing a 5.5 fold increase in comparison to AQ phase
proteins, thus confirming phase separation. Furthermore, a 2.3
fold increase in transmembrane spanning proteins was achieved in
comparisons to control non-enriched tissue from the same brain
region, further confirming the method of enrichment. Proteins
identified within the DT phase included glutamate receptors
(GRIA2, GRIA4), vesicular glutamate transporter (VGLU1), G
Figure 3. Western blotting was carried out to assess trans-
membrane spanning protein MBP and cytosolic protein
GAPDH, on C, DT, AQ, and Pt samples. In a) an increase in MBP
(18–20 kD) expression was confirmed in the DT fraction in comparison
to the AQ fraction, while a considerable amount of MPB was lost to the
Pt. In b) we confirmed depletion of cyotsolic protein GAPDH (40 kD) in
the DT phase, as expected, and confirmed enrichment in the AQ phase.
No GAPDH was lost to the Pt fraction.
doi:10.1371/journal.pone.0039509.g003
Integral Membrane Proteins in Human Brain
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proteins (GPR98, GPC5B), sodium channels (SCNAA, SCN3A,
SCN5A, SCN7A), voltage gated and calcium channels (VDAC1,
VDAC2, VDAC3, CAC1F, CAC1B, CAC1E) synaptic proteins
(SV2A, SYNJ1, SNG3, SYNP2, SNP25, STX1A, etc.), vesicle-
associated membrane proteins (VAPA, VAPB, VAMP2), myelin
related proteins (MBP, PLP, MOG, 2,3 CNP), septin proteins
(SEPT 6–13), calcium transporting subunits, and Rab proteins
(RAB 1-15), all of which are interesting targets and warrant
quantitative investigation in psychiatric [25] and neurological
diseases (Table S2). As this method was designed with quantifi-
cation for clinical investigations in mind, it is important to note
that the data obtained from this analysis is quantitative in the form
of spectral counting [20] or the chromatographic peak area for
relative quantification across samples [26].
In addition to membrane proteins, a large number of
cytoskeletal proteins were present in the DT phase (Figure 4),
which is in keeping with the large overlap in protein identifications
observed between the DT and the Pt fractions (Figure S1), and
with our western blot data which showed MBP to be abundantly
expressed in the Pt fraction (Figure 3a). Indeed, co-localisation of
membrane and cytoskeleton proteins was also observed by
Donoghue PM and colleagues, who assessed Trion-X114 phase
separation on human cardiac tissue [6]. On a different note, it is
important to address the poor overlap in protein identifications by
LC-MS/MS (i.e. 297 proteins) between the DT phase of sample 1
Figure 4. Bar chart (a) illustrates the number of proteins identified in the DT phase, AQ phase, and Pt. The reduction in the number of
proteins identified in the AQ phase can be attributed to the complexity of the sample, as evident from the 1D-SDS gel in figure 3. The amount of
protein present in each phase, as determined by Bradford assay, suggests that the AQ phase is more complex than that of the DT phase and Pt. Bar
chart (b) summarises the sub-cellular location of the identified proteins according to membrane, cytoskeletal, and cyotsolic gene ontologies for the
DT, AQ and Pt fractions. Results confirmed enrichment of membrane proteins in the DT phase, were 344 of the proteins were classified as having a
membrane ontology using GO miner. Results from (a) and (b) are based on the average of two independent samples.
doi:10.1371/journal.pone.0039509.g004
Integral Membrane Proteins in Human Brain
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(661 proteins) and sample 2 (790 proteins). This is most likely due
to the properties of the membrane proteins and their affinity for
the column on the chromatography system, whereby increasing
the number of injections would provide a more accurate
representation of proteins present within each sample. In general,
triplicate runs are suggested for differential expression analysis by
MS [27,28] or multiplexing the samples by labelling peptides (e.g.
iTRAQ) [29] prior to MS can be carried out to overcome the
notorious problem of MS reproducibility [30].
That said, we found the Trion X-114 method to be
reproducible in terms of protein recovery from the three
independent samples assessed, where we obtained similar protein
yields for DT, AQ, and Pt fractions from the three independent
samples, with the average protein yield being 0.45 mg/ml and
1.36 mg/ml for the DT and AQ phases, while 3.4 mg/ml of protein
was lost to the Pt (Table S1). Protein recovery of the DT phase
extract was similar to that observed in human cardiac tissue, where
0.5 mg/ml was obtained for the DT phase extract, and 5 mg/ml was
extracted from the AQ phase [6]. Of the 113 proteins identified in
the DT phase extract of the heart, 34% were assigned a
membrane protein ontology using GO miner. Similarly, findings
of a Triton-X-114 phase separation study on porcine brain
identified 331 proteins in the DT phase, 27% of which were
annotated as membrane proteins. In comparison, our method
identified substantially more unique proteins (1154) and more
membrane proteins, including 494 (54%) proteins with a
membrane protein ontology using GO miner. Also, this is the
first Triton-X114 study to examine the number of transmembrane
helices present for the DT phase following enrichment.
LC-MS/MS analysis identified a total of 384 AQ phase
proteins, where neither cytosolic, cytoskeletal, or membrane sub-
cellular ontology’s were particularly prevalent (Figure 5) and the
number of transmembrane helices present was dramatically
reduced in comparison to DT phase proteins, with an average
of 35 helices present in AQ1 and AQ2 samples. The reduced
number of identifications observed in comparison to DT phase
samples is likely due to 1) AQ phase sample complexity, as
indicated by protein banding pattern in Figure 2, and 2) the
protein yield of 1.36 mg which was considerably larger than that
of the DT phase at 0.45 mg. It’s possible that a 2-Dimensional
fractionation of AQ peptides, prior to MS, would improve
identifications [31]. 2D-LC-MS/MS would increase the orthog-
onality of peptide elution, simplifying the mixture and thus
increasing the number of protein identifications [32]. These results
further highlight the need to pre-fractionate complex protein
samples prior to in-depth LC-MS/MS analysis for successful
biomarker identification.
In addition to analysis of DT and AQ phase extracts, we used
LC-MS/MS to assess protein loss incurred from Triton X-114
separation, whereby the pellet from the initial ultracentrifugation
step was retained and solubilised for analysis. Results indicate that
1.4% of protein is lost to the pellet, along with cell debris prior to
phase separation, including several membrane and cytoskeletal
proteins (Figure 4). However, it is possible to recover the proteins
by introducing a wash step of the pellet and adding the ‘‘wash’’
back to the Triton X-114/PBS supernatant prior to phase
separation.
Finally, this study examined the feasibility of profiling the DT
phase proteins with traditional 2D-PAGE technology, as this is
generally regarded as not suitable for resolving large transmem-
brane spanning proteins. Protein spots were relatively well resolved
on the 2D gel, particularly in the low pH region and in the
medium to high Mw regions, while the basic pH and low Mw
regions were poorly populated, as expected [5]. In contrast, the
AQ phase gel has protein features abundantly distributed across
pH and Mw regions, with several protein spots present at the low
Mw region (Figure S2). To assess DT phase proteins that entered
the gel, we used LC-MS/MS to identify 92 protein spots that were
randomly excised, and the sub-cellular location of the identified
proteins were assessed. Of interest, 66% of the identified DT phase
proteins localised to the membrane, further confirming Triton-
X114 enrichment for membrane proteins. That said, only 2 out of
the 92 proteins identified from the gel had transmembrane helices
(Table S11), suggesting these are membrane associated proteins
rather than integral membrane proteins. While the 2D-PAGE
platform is therefore not recommended for the detection of
transmembrane spanning proteins, the technology is very robust
and reproducible, and should not be discarded lightly for analysis
of more soluble sub-proteomes such as that of the AQ phase
extract.
In conclusion, Triton X-114 phase separation is a simple and
efficient technique for partitioning the proteome into hydropho-
bic and hydrophilic fractions, with minimal protein loss incurred.
This pre-fractionation step offers more flexibility and control
when it comes to sample complexity, as once the DT and AQ
phases are recovered, the appropriate proteomic technique can
Table 1. Summary of the number of transmembrane helices
present in proteins identified in the DT phase, in comparison
to the AQ phase, the recovered Pt, and control non-enriched
tissue.
Predicted Helices DT fraction AQ fraction Pt Control
1 99 16 41 41
2 23 5 7 9
3 8 2 5 6
4 12 2 3 4
5 5 0 1 0
6 12 3 6 2
7 4 1 6 3
8 10 4 2 8
9 4 1 2 3
10 1 2 4 2
11 5 1 2 1
12 5 1 0 3
13 2 0 2 0
14 1 0 1 0
15 0 0 0 0
16 0 0 0 0
17 2 0 1 0
18 0 0 0 0
19 3 0 1 0
20 1 0 1 0
21 2 0 1 0
194 35 83 83
Numbers for each of the Triton X-114 fractions are based on the average of two
samples. Results indicate a clear increase in the number of transmembrane
domains present in proteins from the DT phase, with a 2.3 fold increase (194/
83) in the number of transmembrane proteins identified in comparison to
control non-enriched tissue. The number of helices present in the protein lost
to the Pt fraction, and in that of the control sample are very similar, as expected,
and is in keeping with the protein banding pattern observed in Figure 2.
doi:10.1371/journal.pone.0039509.t001
Integral Membrane Proteins in Human Brain
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Figure 5. Bar chart illustrating the number of transmembrane helices present in proteins identified in the DT phase in comparison
to the AQ phase, Pt, and C sample. Numbers for each fraction are based on the average of two samples. Transmembrane helices for each protein
were assigned online using the TMHMM Server (v 2.0), as described in the methods section.
doi:10.1371/journal.pone.0039509.g005
Figure 6. In part (a) we show a large format 2D-PAGE gel of the DT phase fraction, which was subsequently silver stained for
visualisation of protein spots. We randomly excised and identified 92 of the protein spots from the 2D gel by LC-MS/MS. In part (b) the bar chart
summarises the percentage of membrane, cytoskeletal, and cyotsolic proteins identified by LC-MS/MS from the DT phase gel.
doi:10.1371/journal.pone.0039509.g006
Integral Membrane Proteins in Human Brain
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be applied, based on the biochemical properties of the sub-
proteome. For example, DT phase membrane proteins can be
digested to peptides and samples can be multiplexed by labelling
(e.g. iTRAQ) prior to LC-MS/MS analysis so technical
reproducibility is no longer an issue. In contrast, AQ phase
samples could be assessed by applying a 2-Dimensional technique
such as 2D-PAGE or 2D-LC-MS/MS to further reduce sample
complexity and improve proteome coverage. The Triton X-114
sample preparation method can be applied to a broad range of
organisms and tissue types, and can have several applications.
The information presented creates a valuable resource for future
neuroproteomic studies, where targeted analysis of low abundant,
integral, or otherwise undetectable membrane protein in
desirable in the quest to find disease associated biomarkers and
potential drug targets.
Methods
Triton X-114 Phase Separation
The phase separation was carried out in triplicate, on three
independent samples, with one sample appropriately prepared
for 2D-PAGE and the other two samples reserved for LC-MS/
MS. Healthy human post-mortem brain tissue was obtained from
the Stanley Foundation Brain Consortium (www.
stanleyfoundation.com) and ethical approval (application
no. 080) was granted by the Royal College of Surgeons in
Ireland (RCSI) research ethics committee. Briefly, 250 mg of
insular cortex was sonicated on ice, in 3610 second bursts, in
1 ml of PBS containing protease inhibitor cocktail tablets
(Roche). Once solubilised, the three samples were made up to
8 mls with ice cold PBS containing PIC’s, and 2 mls of 10%
Triton X-114 was added (Calbiochem). Samples were incubated
overnight at 4uC on a rotary shaker. Samples were centrifuged at
20,0006gav for 30 min at 25uC to remove cell debris. The
resulting pellet (Pt) was retained and solublised in 1 ml of 1 M
TEAB buffer (Sigma) for MS (62 samples) and in 2D-PAGE lysis
buffer [7 M urea, 2 M thiourea, 20 mM Tris, 2% CHAPS 2%
DTT, 1.6% pharmalyte, pH 8.5] in order to assess protein loss.
The supernatant was placed at 37uC for 30 min to allow the
Triton X-114 to reach cloud point, and the sample was spun at
5,0006gav for 30 min, at 25uC, to partition the sample into
detergent (DT) and aqueous (AQ) phases. The AQ top layer was
removed to a fresh 50 ml tube to which 2 ml of 10% Triton X-
114 was added, and the DT phase oily pellet was resuspended in
8 mls of cold PBS. Both AQ and DT phases were washed three
times to remove contaminants. Acetone precipitation (80% v/v)
was carried out overnight at 220uC to extract protein from both
AQ and DT phases. Following a 30 minute centrifugation spin at
5,0006gav, at 4uC, precipitated protein extracts were resus-
pended in the appropriate buffer. Fractions from one case were
solubilised in standard 2D-PAGE lysis buffer and fractions from
the other 2 cases were dissolved in 1 ml of 1 M TEAB for LC-
MS/MS analysis. Samples were briefly sonicated to aid protein
solubilisation and protein concentration was determined by the
Bradford dye binding assay (BioRad), according to the
manufacturer instructions.
1D-SDS and Western Blotting
To initially examine Triton X-114 phase partitioning, a 1D-
SDS gel was run and subsequently stained with Coomassie blue to
allow comparison of protein banding patterns between control
non-enriched tissue (C), DT and AQ fractions, and the recovered
Pt. Ten micrograms of protein from each sample was denatured
and solubilized in 26Laemmli buffer (Biorad), and separated on
4–20% gradient, 7 cm, precast acrylamide gels (Pierce). The gel
was stained overnight with colloidal Coomassie Brilliant Blue G-
250 (Biorad). Secondly, western blot analysis was used to assess the
transmembrane spanning protein Myelin Basic Protein (MBP) and
cytosolic protein GAPDH, as previously described [33]. Briefly,
5 mg of protein from C, DT, AQ, and Pt fractions were resolved
on 4–20% gradient, 7 cm, precast acrylamide gels (Pierce). Blots
were incubated overnight at 4uC with primary antibodies against
MBP (chemicon MAB386; 1:1000), and GAPDH (abcam; 1:2000),
as optimised. Species specific secondary antibodies were sourced
from GE Healthcare (RPN2124).
LC-MS/MS of Triton X-114 Fractions
For digestion, 50 mg of protein from DT (62) and AQ (62)
fractions, and the Pt (62) was dried by rotary evaporation under
vacuum (SpeedVac, Savant). As a further control, 50 mg of protein
from non-enriched cortical tissue was digested and run alongside
the Triton X-114 fractions. Samples were resuspended in 20 ml
TEAB, and denatured for 10 min at 80uC in the presence of 10 ml
2% RapiGest (Waters). Samples were reduced with 2 ml (50 mM)
TCEP for 60 min at 60uC, followed by alkylation with 2 mL IAA
(200 mM) for 30 min in the dark. Digestion was initiated by
adding 5 ml of sequence grade modified trypsin (Promega; 1 mg/
ml) to each sample, and samples were incubated overnight at 37uC
on a shaker. Digestion was stopped by adding 5 mL formic acid
(0.1% v/v) and samples were evaporated to dryness. Prior to LC-
MS/MS analysis peptides were resuspended in 3% ACN, 0.1%
FA and peptides were analysed online via the Dionex UltiMateH
3000 HPLC System and the Thermo LTQ-Orbitrap. Protein
identification was performed using MASCOT with Uniprot/
SwissProt release 7.6 used as the search database. Proteins with a
minimum of 2 peptides and MASCOT score greater than or equal
to 30 were deemed identified.
Gene Ontology and Transmembrane Helices Calculations
The sub-cellular location of identified proteins were assigned
online using GoMiner gene ontology clustering software (http://
discover.nci.nih.gov/gominer/ [34]. To predict the number of
transmembrane helices present in identified proteins, the swissprot
accession numbers from each fraction were converted for FASTA
format files with uniprot jobs (http://www.uniprot.org/jobs) and
FASTA files were uploaded to the TMHMM Server v 2.0 (http://
www.cbs.dtu.dk/services/TMHMM/).
2D-PAGE of Phase Fractions
Protein pellets from the acetone precipitated DT and AQ phase
fractions were resuspended in standard 2D-PAGE lysis buffer. 2D-
PAGE was carried out as we described previously (26) on pH 3–
10, 24 cm immobilized pH gradient strips (GE Healthcare). For
protein visualisation the PlusOne Silver Staining kit (GE
Healthcare) was used with modifications to allow for subsequent
identification of protein spots by mass spectrometry analysis. DT
phase protein spots were excised from the 2D gel using a manual
spot picker. Spot plugs were destained and proteins were digested
with trypsin as we previously described [33]. Protein spots were
identified by LC-MS/MS on the Agilent Q-ToF with HPLC Chip
Cube interface (160 nl enrichment column, 75 mm6150 mm
analytical column). Protein identification was performed using
the SpectrumMill search engine (Agilent Technologies), with the
IPI Human v3.61.fasta search database. Proteins with a minimum
peptide score of 6, in combination a %SPI .60 were deemed
identified.
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Supporting Information
Figure S1 Venn Diagram summarising the identified
proteins that overlaped between DT, AQ, and Pt
fractions for both samples that underwent phase
separation and LC-MS/MS analysis.
(TIF)
Figure S2 Proteins spot patterns from the a) DT and b)
AQ phase fractions that underwent 2D-PAGE and silver
staining. The AQ phase pattern is more complex than that of the
DT phase, with an increased number of protein spots at both the
high and medium Mw regions, in keeping with previous
observations in the protein assay, and coomassie blue staining of
1D SDS gels.
(TIF)
Table S1 Protein assay results for DT, AQ, and Pt
fractions from the three independent samples that
underwent Triton X-114 phase separation.
(XLS)
Table S2 Unique DT proteins identified from DT1 and
DT2 samples that underwent LC-MS/MS.
(XLS)
Table S3 Proteins identified in DT1 by LC-MS/MS. The
protein Score, Mass, and number of Peptides identified for each
protein are listed in columns D, E, and F respectively.
(XLS)
Table S4 Proteins identified in DT2 by LC-MS/MS. The
protein Score, Mass, and number of Peptides identified for each
protein are listed in columns D, E, and F respectively.
(XLS)
Table S5 Unique AQ phase proteins identified from
AQ1 and AQ2 samples that underwent LC-MS/MS.
(XLS)
Table S6 Proteins identified in AQ1 by LC-MS/MS. The
protein Score, Mass, and number of Peptides identified for each
protein are listed in columns D, E, and F respectively.
(XLS)
Table S7 Proteins identified in AQ2 by LC-MS/MS. The
protein Score, Mass, and number of Peptides identified for each
protein are listed in columns D, E, and F respectively.
(XLS)
Table S8 Proteins identified in Pt1 by LC-MS/MS. The
protein Score, Mass, and number of Peptides identified for each
protein are listed in columns D, E, and F respectively.
(XLS)
Table S9 Proteins identified in Pt2 by LC-MS/MS. The
protein Score, Mass, and number of Peptides identified for each
protein are listed in columns D, E, and F respectively.
(XLS)
Table S10 Proteins identified in control non-enriched
tissue from the Insular Cortex. The protein Score, Mass, and
number of Peptides identified for each protein are listed in
columns D, E, and F respectively.
(XLS)
Table S11 Proteins excised and identified from the
silver stained 2D-PAGE gel of the DT phase extract. A
total of 77 unique proteins were identified by LC-MS/MS.
Proteins marked with * have transmembrane helices present.
(XLS)
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